Artículos de revistas
The Network Interaction Of The Human Cytosolic 90kda Heat Shock Protein Hsp90: A Target For Cancer Therapeutics
Registro en:
Journal Of Proteomics. , v. 75, n. 10, p. 2790 - 2802, 2012.
10.1016/j.jprot.2011.12.028
Autor
da Silva V.C.H.
Ramos C.H.I.
Institución
Resumen
In the cell, proteins interact within a network in which a small number of proteins are highly connected nodes or hubs. A disturbance in the hub proteins usually has a higher impact on the cell physiology than a disturbance in poorly connected nodes. In eukaryotes, the cytosolic Hsp90 is considered to be a hub protein as it interacts with molecular chaperones and co-chaperones, and has key regulatory proteins as clients, such as transcriptional factors, protein kinases and hormone receptors. The large number of Hsp90 partners suggests that Hsp90 is involved in very important functions, such as signaling, proteostasis and epigenetics. Some of these functions are dysregulated in cancer, making Hsp90 a potential target for therapeutics. The number of Hsp90 interactors appears to be so large that a precise answer to the question of how many proteins interact with this chaperone has no definitive answer yet, not even if the question refers to specific Hsp90s as one of the human cytosolic forms. Here we review the major chaperones and co-chaperones that interact with cytosolic Hsp90s, highlighting the latest findings regarding client proteins and the role that posttranslational modifications have on the function and interactions of these molecular chaperones. This article is part of a Special Issue entitled: Proteomics: The clinical link. © 2011 Elsevier B.V.. 75 10 2790 2802 Dyson, H.J., Wright, P.E., Unfolded proteins and protein folding studied by NMR (2004) Chem Rev, 104, pp. 3607-3622 Tompa, P., The interplay between structure and function in intrinsically unstructured proteins (2005) FEBS Lett, 579, pp. 3346-3354 Hartl, F.U., Chaperone-assisted protein folding: the path to discovery from a personal perspective (2011) Nat Med, 17, pp. 1206-1210 Horwich, A.L., Protein folding in the cell: an inside story (2011) Nat Med, 17, pp. 1211-1216 Bukau, B., Weissman, J., Horwich, A., Molecular chaperones and protein quality control (2006) Cell, 125, pp. 443-451 Hartl, F.U., Bracher, A., Hayer-Hartl, M., Molecular chaperones in protein folding and proteostasis (2011) Nature, 475, pp. 324-332 Tiroli-Cepeda, A., Ramos, C.H.I., An overview of the role of molecular chaperones in protein homeostasis (2011) Protein Pept Lett, 18, pp. 101-109 Ramos, C.H.I., Ferreira, S.T., Protein folding, misfolding and aggregation: evolving concepts and conformational diseases (2005) Protein Pept Lett, 12, pp. 213-222 Luheshi, L.M., Crowther, D.C., Dobson, C.M., Protein misfolding and disease: from the test tube to the organism (2008) Curr Opin Chem Biol, 12, pp. 25-31 Kikis, E.A., Gidalevitz, T., Morimoto, R.I., Protein homeostasis in models of aging and age-related conformational disease (2010) Adv Exp Med Biol, 694, pp. 138-159 Anderson, J.F., Siller, E., Barral, J.M., Disorders of protein biogenesis and stability (2011) Protein Pept Lett, 18, pp. 110-121 Georgakis, G.V., Li, Y., Younes, A., The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphomacell lines by depleting cyclin D1, Akt, Bid and activating caspase 9 (2006) Br J Haematol, 135, pp. 68-71 Ahmad, N., Kumar, R., Steroid hormone receptors in cancer development: a target for cancer therapeutics (2011) Cancer Lett, 300, pp. 1-9 Echeverría, P.C., Picard, D., Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility (2010) Biochim Biophys Acta, 1803, pp. 641-649 Soussi, T., Legros, Y., Lubin, R., Ory, K., Schlichtholz, B., Multifactorial analysis of p53 alteration in human cancer: a review (1994) Int J Cancer, 57, pp. 1-9 Vogelstein, B., Lane, D., Levine, A.J., Surfing the p53 network (2000) Nature, 408, pp. 307-310 Römer, L., Klein, C., Dehner, A., Kessler, H., Buchner, J., P53-a natural cancer killer: structural insights and therapeutic concepts (2006) Angew Chem Int Ed Eng, 45, pp. 6440-6460 Maki, C.G., Huibregtse, J.M., Howley, P.M., In vivo ubiquitination and proteasome-mediated degradation of p53 (1996) Cancer Res, 56, pp. 2649-2654 Soussi, T., The p53 tumor suppressor gene: from molecular biology to clinical investigation (2000) Ann N Y Acad Sci, 910, pp. 121-139 Lin, K., Rockliffe, N., Johnson, G.G., Sherrington, P.D., Pettitt, A.R., Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cellsHsp90 inhibition and p53/ATM status in CLL (2008) Oncogene, 27, pp. 2445-2455 Fukumoto, R., Kiang, J.G., Geldanamycin analog 17-DMAG limits apoptosis in human peripheral blood cells by inhibition of p53 activation and its interaction with heat-shock protein 90kDa after exposure to ionizing radiation (2011) Radiat Res, 176, pp. 333-345 Mollapour, M., Neckers, L., Post-translational modifications of Hsp90 and their contributions to chaperone regulation (2011) Biochim Biophys Acta, , doi: doi:10.1016/j.bbamcr.2011.07.018 DeZwaan, D.C., Freeman, B.C., HSP90 manages the ends (2010) Trends Biochem Sci, 35, pp. 384-391 Lydall, D., Taming the tiger by the tail: modulation of DNA damage responses by telomeres (2009) EMBO J, 28, pp. 2174-2187 Holt, S.E., Aisner, D.L., Baur, J., Tesmer, V.M., Dy, M., Ouellette, M., Functional requirement of p23 and Hsp90 in telomerase complexes (1999) Genes Dev, 13, pp. 817-826 Forsythe, H.L., Jarvis, J.L., Turner, J.W., Elmore, L.W., Holt, S.E., Stable association of HSP90 and p23, but not Hsp70, with active human telomerase (2001) J Biol Sci, 276, pp. 15571-15574 DeZwaan, D.C., Toogun, O.A., Echtenkamp, F.J., Freeman, B.C., The Hsp82 molecular chaperone promotes a switch between unextendable and extendable telomere states (2009) Nat Struct Mol Biol, 16, pp. 711-716 Laskar, S., Bhattacharyya, M.K., Shankar, R., Bhattacharyya, S., HSP90 controls SIR2 mediated gene silencing (2011) PLoS One, 6, pp. e23406 Barral, J.M., Hutagalung, A.H., Brinker, A., Hartl, F.U., Epstein, H.F., Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin (2002) Science, 295, pp. 669-671 Willis, M.S., Schisler, J.C., Portbury, A.L., Patterson, C., Build it up-tear it down: protein quality control in the cardiac sarcomere (2009) Cardiovasc Res, 81, pp. 439-448 Gaiser, A.M., Kaiser, C.J.O., Haslbeck, V., Richter, K., Downregulation of the Hsp90 system causes defects in muscle cells of Caenorhabditis elegans (2011) PLoS One, 6, pp. e25485 Voellmy, R., Boellmann, F., Chaperone regulation of the heat shock protein response (2007) Adv Exp Med Biol, 594, pp. 89-99 Jakob, U., Lilie, H., Meyer, I., Buchner, J., Transient interaction of Hsp90 with early unfolding intermediates of citrate synthase. Implications for heat shock in vivo (1995) J Biol Chem, 270, pp. 7288-7294 Francis, B.R., Thorsness, P.E., Hsp90 and mitochondrial proteases Yme1 and Yta10/12 participate in ATP synthase assembly in Saccharomyces cerevisiae (2011) Mitochondrion, 1, pp. 587-600 Lees-Miller, S.P., Anderson, C.W., The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, Hsp90α at two NH2-terminal threonine residues (1989) J Biol Chem, 264, pp. 17275-17280 Lees-Miller, S.P., Anderson, C.W., Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved (1989) J Biol Chem, 264, pp. 2431-2437 Brouet, A., Sonveaux, P., Dessy, C., Moniotte, S., Balligand, J.L., Feron, O., Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins (2001) Circ Res, 89, pp. 866-873 Ogiso, H., Kagi, N., Matsumoto, E., Nishimoto, M., Arai, R., Shirouzu, M., Phosphorylation analysis of 90kDa heat shock protein within the cytosolic aryl-hydrocarbon receptor complex (2004) Biochemistry, 43, pp. 15510-15519 Duval, M., Le Boeuf, F., Huot, J., Gratton, J.P., Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase (2007) Mol Biol Cell, 18, pp. 4659-4668 Kurokawa, M., Zhao, C., Reya, T., Kornbluth, S., Inhibition of apoptosome formation by suppression of Hsp90β phosphorylation in tyrosine kinase-induced leukemias (2008) Mol Cell Biol, 28, pp. 5494-5506 Deb, T.B., Zuo, A.H., Wang, Y., Barndt, R.J., Cheema, A.K., Sengupta, S., Pnck induces ligand-independent EGFR degradation by probable perturbation of the Hsp90 chaperone complex (2011) Am J Physiol Cell Physiol, 300, pp. 1139-1154 Mollapour, M., Tsutsumi, S., Truman, A.W., Xu, W., Vaughan, C.K., Beebe, K., Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity (2011) Mol Cell, 41, pp. 672-681 Scroggins, B.T., Robzyk, K., Wang, D., Marcu, M.G., Tsutsumi, S., Beebe, K., An acetylation site in the middle domain of Hsp90 regulates chaperone function (2007) Mol Cell, 25, pp. 151-159 Prodromou, C., Pearl, L.H., Structure and functional relationships of Hsp90 (2003) Curr Cancer Drug Targets, 3, pp. 301-323 Yang, Y., Rao, R., Shen, J., Tang, Y., Fiskus, W., Nechtman, J., Role of acetylation and extracellular location of heat shock protein 90α in tumor cell invasion (2008) Cancer Res, 68, pp. 4833-4842 Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally (2008) Mol Cell Biol, 28, pp. 1688-1701 Zhou, Q., Agoston, A.T., Atadja, P., Nelson, W.G., Davidson, N.E., Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells (2008) Mol Cancer Res, 6, pp. 873-883 Gao, C., Guo, H., Wei, J., Mi, Z., Wai, P.Y., Kuo, P.C., Identification of S-nitrosylated proteins in endotoxin-stimulated RAW264.7 murine macrophages (2005) Nitric Oxide, 12, pp. 121-126 Martinez-Ruiz, A., Villanueva, L., Gonzalez De Orduna, C., Lopez-Ferrer, D., Higueras, M.A., Tarin, C., S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities (2005) Proc Natl Acad Sci U S A, 102, pp. 8525-8530 Zhang, Y., Keszler, A., Broniowska, K.A., Hogg, N., Characterization and application of the biotin-switch assay for the identification of S-nitrosated proteins (2005) Free Radic Biol Med, 38, pp. 874-881 Retzlaff, M., Stahl, M., Eberl, H.C., Lagleder, S., Beck, J., Kessler, H., Hsp90 is regulated by a switch point in the C-terminal domain (2009) EMBO Rep, 10, pp. 1147-1153 Zhao, Y.G., Gilmore, R., Leone, G., Coffey, M.C., Weber, B., Lee, P.W., Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein (2001) J Biol Chem, 276, pp. 32822-32827 Mollapour, M., Tsutsumi, S., Neckers, L., Hsp90 phosphorylation, Wee1 and the cell cycle (2010) Cell Cycle, 9, pp. 2310-2316 Murtagh, J., Lu, H., Schwartz, E.L., Taxotere-induced inhibition of human endothelial cell migration is a result of heat shock protein 90 degradation (2006) Cancer Res, 66, pp. 8192-8199 Taipale, M., Jarosz, D.F., Lindquist, S., HSP90 at the hub of protein homeostasis: emerging mechanistic insights (2010) Nat Rev Mol Cell Biol, 11, pp. 515-528 Prodromou, C., Siligardi, G., O'Brien, R., Woolfson, D.N., Regan, L., Panaretou, B., Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones (1999) EMBO J, 18, pp. 754-762 Southworth, D.R., Agard, D.A., Client-loading conformation of the Hsp90 molecular chaperone revealed in the cryo-EM structure of the human Hsp90:Hop complex (2011) Mol Cell, 42, pp. 771-781 Das, A.K., Cohen, P.W., Barford, D., The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein-protein interactions (1998) EMBO J, 17, pp. 1192-1199 Cliff, M.J., Williams, M.A., Brooke-Smith, J., Barford, D., Ladbury, J.E., Molecular recognition via coupled folding and binding in a TPR domain (2005) J Mol Biol, 346, pp. 717-732 Cliff, M.J., Harris, R., Barford, D., Ladbury, J.E., Williams, M.A., Conformational diversity in the TPR domain-mediated interaction of protein phosphatase 5 with Hsp90 (2006) Structure, 14, pp. 415-426 Zhang, M., Windheim, M., Roe, S.M., Peggie, M., Cohen, P., Prodromou, C., Chaperoned ubiquitylation-crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIPUbc13-Uev1a complex (2005) Mol Cell, 20, pp. 525-538 Cheung-Flynn, J., Roberts, P.J., Riggs, D.L., Smith, D.F., C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90 (2003) J Biol Chem, 278, pp. 17388-17394 Young, J.C., Hoogenraad, N.J., Hartl, F.U., Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70 (2003) Cell, 112, pp. 41-50 Li, J., Qian, X., Hu, J., Sha, B., Molecular chaperone Hsp70/Hsp90 prepares the mitochondrial outer membrane translocon receptor Tom71 for preprotein loading (2009) J Biol Chem, 284, pp. 23852-23859 Jascur, T., Brickner, H., Salles-Passador, I., Barbier, V., El Khissiin, A., Smith, B., Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein (2005) Mol Cell, 17, pp. 237-249 Makhnevych, T., Houry, W.A., The role of Hsp90 in protein complex assembly (2011) Biochim Biophys Acta, , doi:10.1016/j.bbamcr.2011.09.001 Carrello, A., Ingley, E., Minchin, R.F., Tsai, S., Ratajczak, T., The common tetratricopeptide repeat acceptor site for steroid receptor- associated immunophilins and Hop is located in the dimerization domain of Hsp90 (1999) J Biol Chem, 274, pp. 2682-2689 Mayr, C., Richter, K., Lilie, H., Buchner, J., Cpr6 and Cpr7, two closely related Hsp90-associated immunophilins from Saccharomyces cerevisiae, differ in their functional properties (2000) J Biol Chem, 275, pp. 34140-34146 Meyer, B.K., Perdew, G.H., Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization (1999) Biochemistry, 38, pp. 8907-8917 Boulon, S., Marmier-Gourrier, N., Pradet-Balade, B., Wurth, L., Verheggen, C., Jady, B.E., The Hsp90 chaperone controls the biogenesis of L7Ae RNPs through conserved machinery (2008) J Cell Biol, 180, pp. 579-595 Millson, S.H., Vaughan, C.K., Zhai, C., Ali, M.M., Panaretou, B., Piper, P.W., Chaperone ligand-discrimination by the TPR-domain protein Tah1 (2008) Biochem J, 413, pp. 261-268 Chadli, A., Graham, J.D., Abel, M.G., Jackson, T.A., Gordon, D.F., Wood, W.M., GCUNC-45 is a novel regulator for the progesterone receptor/hsp90 chaperoning pathway (2006) Mol Cell Biol, 26, pp. 1722-1730 Millson, S.H., Truman, A.W., King, V., Prodromou, C., Pearl, L.H., Piper, P.W., A two-hibrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p (Mpk1p) (2005) Eukaryot Cell, 4, pp. 849-860 Roe, S.M., Ali, M.M., Meyer, P., Vaughan, C.K., Panaretou, B., Piper, P.W., The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50cdc37 (2004) Cell, 116, pp. 87-98 Zhao, R., Davey, M., Hsu, Y.C., Kaplanek, P., Tong, A., Parsons, A.B., Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone (2005) Cell, 120, pp. 715-727 Johnson, J.L., Toft, D.O., Binding of p23 and hsp90 during assembly with the progesterone receptor (1995) Mol Endocrinol, 9, pp. 670-678 Sreedhar, A.S., Kalmár, E., Csermely, P., Shen, Y.F., Hsp90 isoforms: functions, expression and clinical importance (2004) FEBS Lett, 562, pp. 11-15 Koulov, A.V., Lapointe, P., Lu, B., Razvi, A., Coppinger, J., Dong, M.Q., Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis (2010) Mol Biol Cell, 21, pp. 871-884 Adwan, T.S., Ohm, A.M., Jones, D.M.N., Humphries, M.J., Reyland, M.E., Regulated binding of importin-α to PKCδ in response to apoptotic signals facilitates nuclear import (2011) JBC, 286, pp. 35716-35724 Ha, K., Fiskus, W., Rao, R., Balusu, R., Venkannagari, S., Nalabothula, N.R., Hsp90 inhibitor-mediated disruption of chaperone association of ATR with Hsp90 sensitizes cancer cells to DNA damage (2011) Mol Cancer Ther, 10, pp. 1194-1206 Kim, Y.M., Pyo, H., Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell lines (2012) DNA Cell Biol, 31, pp. 15-29 Joo, J.H., Dorsey, F.C., Joshi, A., Hennessy-Walters, K.M., Rose, K.L., McCastlain, K., Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy (2011) Mol Cell, 43, pp. 572-585 Fukushima, T., Okajima, H., Yamanaka, D., Ariga, M., Nagata, S., Ito, A., HSP90 interacting with IRS-2 is involved in cAMP-dependent potentiation of IGF-I signals in FRTL-5 cells (2011) Mol Cell Endocrinol, 344, pp. 81-89 Knobbe, C., Revett, T., Bai, Y., Chow, V., Jeon, A.H.W., Bohm, C., Choice of bioloical source material supersedes oxidative stress in its influence on DJ-1 in vivo interactions with Hsp90 (2011) J Proteome Res, 10, pp. 4388-4404 Jin, Y., Zhen, Y., Haugsten, E.M., Wiedlocha, A., The driver of malignancy in KG-1a leukemic cells, FGFR1OP2-FGFR1, encodes an HSP90 addicted oncoprotein (2011) Cell Signal, 23, pp. 1758-1766 Wang, T., Zhang, M., Ma, Z., Guo, K., Tergaonkar, V., Zeng, Q., Hong, W., A role of Rab7 in stabilizing EGFR-Her2 and in sustaining Akt survival signal (2011) J Cell Physiol, , doi:10.1002/jcp.23023 Kim, Y.J., Lee, S.A., Myung, S.C., Kim, W., Lee, C.S., Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins (2012) Mol Cell Biochem, 359, pp. 33-43 Chen, B., Piel, W.H., Gui, L., Bruford, E., Monteiro, A., The HSP90 family of genes in the human genome: insights into their divergence and evolution (2005) Genomics, 86, pp. 627-637 Kekatpure, V.D., Dannenberg, A.J., Subbaramaiah, K., HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling (2009) J Biol Chem, 284, pp. 7436-7445 Carbone, D.L., Doorn, J.A., Kiebler, Z., Ickes, B.R., Petersen, D.R., Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease (2005) J Pharmacol Exp Ther, 315, pp. 8-15 Kundrat, L., Regan, L., Identification of residues on Hsp70 and Hsp90 ubiquitinated by the cochaperone CHIP (2010) J Mol Biol, 395, pp. 587-594 Mollapour, M., Tsutsumi, S., Donnelly, A.C., Beebe, K., Tokita, M.J., Lee, M.J., Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function (2010) Mol Cell, 37, pp. 333-343 Bennetzen, M.V., Larsen, D.H., Bunkenborg, J., Bartek, J., Lukas, J., Andersen, J.S., Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response (2010) Mol Cell Proteomics, 9, pp. 1314-1323 Wang, Z., Gucek, M., Hart, G.W., Cross-talk between GlcNAcyla Hoffmann, T., Hovemann, B., Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related genes encode formerly identified tumour-specific transplantation antigens (1988) Gene, 74, pp. 491-501 Chen, B., Piel, W.H., Gui, L., Bruford, E., Monteiro, A., The HSP90 family of genes in the human genome: insights into their divergence and evolution (2005) Genomics, 86, pp. 627-637 Eustace, B.K., Sakurai, T., Stewart, J.K., Yimlamai, D., Unger, C., Zehetmeier, C., Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness (2004) Nat Cell Biol, 6, pp. 507-514 Richter, K., Buchner, J., Hsp90: twist and fold (2006) Cell, 127, pp. 251-253 Pearl, L.H., Prodromou, C., Structure and mechanism of the Hsp90 molecular chaperone machinery (2006) Annu Rev Biochem, 75, pp. 271-294 Ali, M.M., Roe, S.M., Vaughan, C.K., Meyer, P., Panaretou, B., Piper, P.W., Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex (2006) Nature, 440, pp. 1013-1017 Mayer, M.P., Gymnastics of Molecular Chaperones, Mol (2010) Cell, 39, pp. 321-331 Krukenberg, K.A., Street, T.O., Lavery, L.A., Agard, D.A., Conformational dynamics of the molecular chaperone Hsp90 (2011) Q Rev Biophys, 44, pp. 229-255 Chiosis, G., Vilenchik, M., Kim, J., Solit, D., Hsp90: the vulnerable chaperone (2004) Drug Discov Today, 9, pp. 881-888 Johnson, J.L., Brown, C., Plasticity of the Hsp90 chaperone machine in divergent eukaryotic organisms (2009) Cell Stress Chaperones, 14, pp. 83-94 Russell, L.C., Whitt, S.R., Chen, M.S., Chinkers, M., Identification of conserved residues required for the binding of a tetratricopeptide repeat domain to heat shock protein 90 (1999) J Biol Chem, 274, pp. 20060-20063 Odunuga, O.O., Longshaw, V.M., Blatch, G.L., Hop: more than an Hsp70/Hsp90 adaptor protein (2004) Bioessays, 26, pp. 1058-1068 Murata, S., Chiba, T., Tanaka, K., CHIP: a quality-control E3 ligase collaborating with molecular chaperones (2003) Int J Biochem Cell Biol, 35, pp. 572-578 Yang, J., Roe, S.M., Cliff, M.J., Williams, M.A., Ladbury, J.E., Cohen, P.T., Molecular basis for TPR domain-mediated regulation of protein phosphatase 5 (2005) EMBO J, 24, pp. 1-10 Fan, A.C., Young, J.C., Function of cytosolic chaperones in Tom70-mediated mitochondrial import (2011) Protein Pept Lett, 18, pp. 122-131 Miyata, Y., Chambraud, B., Radanyi, C., Leclerc, J., Lebeau, M.C., Renoir, J.M., Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding activity of FKBP52 (1997) Proc Natl Acad Sci U S A, 94, pp. 14500-14505 Longshaw, V.M., Dirr, H.W., Blatch, G.L., Lässle, M., The in vitro phosphorylation of the co-chaperone mSTI1 by cell cycle kinases substantiates a predicted casein kinase II-p34cdc2-NLS (CcN) motif (2000) Biol Chem, 381, pp. 1133-1138 Kobayashi, T., Nakatani, Y., Tanioka, T., Tsujimoto, M., Nakajo, S., Nakaya, K., Regulation of cytosolic prostaglandin E synthase by phosphorylation (2004) Biochem J, 381, pp. 59-69 Johnson, B.D., Schumacher, R.J., Ross, E.D., Toft, D.O., Hop modulates Hsp70/Hsp90 interactions in protein folding (1998) J Biol Chem, 273, pp. 3679-3686 Grenert, J.P., Johnson, B.D., Toft, D.O., The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes (1999) J Biol Chem, 274, pp. 17525-17533 Wegele, H., Wandinger, S.K., Schmid, A.B., Reinstein, J., Buchner, J., Substrate transfer from the chaperone Hsp70 to Hsp90 (2006) J Mol Biol, 356, pp. 802-811 Scheufler, C., Brinker, A., Bourenkov, G., Pegoraro, S., Moroder, L., Bartunik, H., Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine (2000) Cell, 101, pp. 199-210 Onuoha, S.C., Coulstock, E.T., Grossmann, J.G., Jackson, S.E., Structural studies on the co-chaperone Hop and its complexes with Hsp90 (2008) J Mol Biol, 379, pp. 732-744 Gonçalves, D.C., Gava, L.M., Ramos, C.H.I., Human Hsp70/Hsp90 organizing protein (Hop) D456G is a mixture of monomeric and dimeric species (2010) Protein Pept Lett, 17, pp. 492-498 Yi, F., Doudevski, I., Regan, L., HOP is a monomer: investigation of the oligomeric state of the co-chaperone HOP (2010) Protein Sci, 19, pp. 19-25 Ebong, I.O., Morgner, N., Zhou, M., Saraiva, M.A., Daturpalli, S., Jackson, S.E., Heterogeneity and dynamics in the assembly of the Heat Shock Protein 90 chaperone complexes (2011) Proc Natl Acad Sci U S A, 108, pp. 17939-17944 Gava, L.M., Gonçalves, D.C., Borges, J.C., Ramos, C.H.I., Stoichiometry and thermodynamics of the interaction between the C-terminus of human 90kDa heat shock protein Hsp90 and the mitochondrial translocase of outer membrane Tom70 (2011) Arch Biochem Biophys, 513, pp. 119-125 Cortajarena, A.L., Yi, F., Regan, L., Designed TPR modules as novel anticancer agents (2008) ACS Chem Biol, 3, pp. 161-166 Yi, F., Regan, L., A novel class of small molecule inhibitors of Hsp90 (2008) ACS Chem Biol, 3, pp. 645-654 Pimienta, G., Herbert, K.M., Regan, L., A compound that inhibits the HOP-Hsp90 complex formation and has unique killing effects in breast cancer cell lines (2011) Mol Pharmacol, 8, pp. 2252-2261 Walsh, N., Larkin, A.M., Swan, N., Conlon, K., Dowling, P., McDermott, R., RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation (2011) Cancer Lett, 306, pp. 180-189 Connell, P., Ballinger, C.A., Jiang, J., Wu, Y., Thompson, L.J., Hohfeld, J., The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins (2001) Nat Cell Biol, 3, pp. 93-96 Zhou, P., Fernandes, N., Dodge, I.L., Reddi, A.L., Rao, N., Safran, H., ErbB2 degradation mediated by the co-chaperone protein CHIP (2003) J Biol Chem, 278, pp. 13829-13837 Zhang, L., Nephew, K.P., Gallagher, P.J., Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes (2007) J Biol Chem, 282, pp. 11795-11804 Kajiro, M., Hirota, R., Nakajima, Y., Kawanowa, K., So-ma, K., Ito, I., The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways (2009) Nat Cell Biol, 11, pp. 312-319 Yan, S., Sun, X., Xiang, B., Cang, H., Kang, X., Chen, Y., Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90 (2010) EMBO J, 29, pp. 3773-3786 Mclaughlin, S.H., Sobott, F., Yao, Z.P., Zhang, W., Nielsen, P.R., Grossmann, J.G., The co- chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins (2006) J Mol Biol, 356, pp. 746-758 Panaretou, B., Siligardi, G., Meyer, P., Maloney, A., Sullivan, J.K., Singh, S., Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone Aha1 (2002) Mol Cell, 10, pp. 1307-1318 Meyer, P., Prodromou, C., Liao, C., Hu, B., Roe, S.M., Vaughan, C.K., Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery (2004) EMBO J, 23, pp. 511-519 Harst, A., Lin, H., Obermann, W.M., Aha1 competes with Hop, p50 and p23 for binding to the molecular chaperone Hsp90 and contributes to kinase and hormone receptor activation (2005) Biochem J, 387, pp. 789-796 Retzlaff, M., Hagn, F., Mitschke, L., Hessling, M., Gugel, F., Kessler, H., Asymmetric activation of the hsp90 dimer by its cochaperone Aha1 (2010) Mol Cell, 37, pp. 344-354 Holmes, J.L., Sharp, S.Y., Hobbs, S., Workman, P., Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90inhibitor 17-allylamino-17-demethoxygeldanamycin (2008) Cancer Res, 68, pp. 1188-1197 Mandal, A.K., Lee, P., Chen, J.A., Nillegoda, N., Heller, A., DiStasio, S., Cdc37 has distinct roles in protein kinase quality control that protect nascent chains from degradation and promote posttranslational maturation (2007) J Cell Biol, 176, pp. 319-328 Smith, J.R., Workman, P., Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning (2009) Cell Cycle, 8, pp. 362-372 Zhang, T., Hamza, A., Cao, X., Wang, B., Yu, S., Zhan, C.G., A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells (2008) Mol Cancer Ther, 7, pp. 162-170 Wandinger, S.K., Suhre, M.H., Wegele, H., Buchner, J., The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90 (2006) EMBO J, 25, pp. 367-376 Vaughan, C.K., Mollapour, M., Smith, J.R., Truman, A., Hu, B., Good, V.M., Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37 (2008) Mol Cell, 31, pp. 886-895 Jeong, H., Mason, S.P., Barabasi, A.L., Oltvai, Z.N., Lethality and centrality in protein networks (2001) Nature, 411, pp. 41-42 Higurashi, M., Ishida, T., Kinoshita, K., Identification of transient hub proteins and the possible structural basis for their multiple interactions (2008) Protein Sci, 17, pp. 72-78 Ekman, D., Light, S., Björklund, A.K., Elofsson, A., What properties characterize the hub proteins of the protein-protein interaction network of Saccharomyces cerevisiae? (2006) Genome Biol, 7, pp. R45 Zhao, R., Davey, M., Hsu, Y.C., Kaplanek, P., Tong, A., Parsons, A.B., Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone (2005) Cell, 120, pp. 715-727 Batada, N.N., Hurst, L.D., Tyers, M., Evolutionary and physiological importance of hub proteins (2006) PLoS Comput Biol, 2, pp. e88 Patil, A., Nakamura, H., Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks (2006) FEBS Lett, 580, pp. 2041-2045 McClellan, A.J., Xia, Y., Deutschbauer, A.M., Davis, R.W., Gerstein, M., Frydman, J., Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches (2007) Cell, 13, pp. 1121-1135 Workman, P., Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone (2004) Cancer Lett, 206, pp. 149-157 Sharp, S., Workman, P., Inhibitors of the HSP90 molecular chaperone: current status (2006) Adv Cancer Res, 95, pp. 323-348 Neckers, L., Heat shock protein 90: the cancer chaperone (2007) J Biosci, 32, pp. 517-530 Pearl, L.H., Prodromou, C., Workman, P., The Hsp90 molecular chaperone: an open and shut case for treatment (2008) Biochem J, 410, pp. 439-453 Gava, L., Ramos, C.H.I., Human 90kDa heat shock protein Hsp90 as a target for cancer therapeutics (2009) Curr Chem Biol, 3, pp. 330-341 Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100, pp. 57-70 Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation (2011) Cell, 144, pp. 646-674 Whitesell, L., Bagatell, R., Falsey, R., The stress response: implications for the clinical development of hsp90 inhibitors (2003) Curr Cancer Drug Targets, 3, pp. 349-358 Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M.F., Fritz, L.C., A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors (2003) Nature, 425, pp. 407-410 Taldone, T., Chiosis, G., Purine-scaffold Hsp90 inhibitors (2009) Curr Top Med Chem, 9, pp. 1436-1446 Salminen, A., Ojala, J., Kaarniranta, K., Hiltunen, M., Soininen, H., Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease (2011) Prog Neurobiol, 93, pp. 99-110 Shonhai, A., Maier, A.G., Przyborski, J.M., Blatch, G.L., Intracellular protozoan parasites of humans: the role of molecular chaperones in development and pathogenesis (2011) Protein Pept Lett, 18, pp. 143-157 Cowen, L.E., Singh, S.D., Köhler, J.R., Collins, C., Zaas, A.K., Schell, W.A., Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease (2009) Proc Natl Acad Sci U S A, 106, pp. 2818-2823 Chase, G., Deng, T., Fodor, E., Leung, B.W., Mayer, D., Schwemmle, M., Hsp90 inhibitors reduce influenza virus replication in cell culture (2008) Virology, 377, pp. 431-439 Brugge, J.S., Interaction of the Rous sarcoma virus protein pp 60v-src with the cellular proteins pp50 and pp90 (1986) Curr Top Microbiol Immunol, 123, pp. 1-22 Xu, Y., Lindquist, S., Heat-shock protein Hsp90 governs the activity of pp 60v-src kinase (1993) Proc Natl Acad Sci U S A, 90, pp. 7074-7078 Di Cosimo, S., Baselga, J., Targeted therapies in breast cancer: where are we now? (2008) Eur J Cancer, 44, pp. 2781-2790 Yarden, Y., Kuang, W.J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T.J., Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand (1987) EMBO J, 6, pp. 3341-3351 Matthews, W., Jordan, C.T., Wiegand, G.W., Pardoll, D., Lemischka, I.R., A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations (1991) Cell, 65, pp. 1143-1152 Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product (1993) J Clin Invest, 92, pp. 1736-1744 Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors (1998) Science, 279, pp. 577-580 Fumo, G., Akin, C., Metcalfe, D.D., Neckers, L., 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in downregulating mutated, constitutively activated KIT protein in human mast cells (2004) Blood, 103, pp. 1078-1084 Banerji, U., O'Donnell, A., Scurr, M., Pacey, S., Stapleton, S., Asad, Y., Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies (2005) J Clin Oncol, 23, pp. 4152-4161 Dias, S.R., Friedlos, F., Light, Y., Springer, C., Workman, P., Marais, R., Activated B-RAF is an Hsp90 client protein that is targeted by the anticancer drug 17-allylamino-17-demethoxygeldanamycin (2005) Cancer Res, 65, pp. 10686-10691 Grbovic, O.M., Basso, A.D., Sawai, A., Ye, Q., Friedlander, P., Solit, D., V600E BRaf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors (2006) Proc Natl Acad Sci U S A, 103, pp. 57-62 Fukuyo, Y., Inoue, M., Nakajima, T., Higashikubo, R., Horikoshi, N.T., Hunt, C., Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives (2008) Cancer Res, 68, pp. 6324-6330 Mehta, P.P., Kung, P., Yamazaki, S., Walls, M., Shen, A., Nguyen, L., A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells (2011) Cancer Lett, 300, pp. 30-39 Lewis, J., Devin, A., Miller, A., Lin, Y., Rodriguez, Y., Neckers, L., Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation (2000) J Biol Chem, 275, pp. 10519-10526